MedWatch

Business angels grant millions to company behind urinary catheter for women

The small Danish medtech company MagCath is approaching its most comprehensive clinical trial so far and hopes to receive CE marking of its product next year. To finance the trial, the company has joined forces with a group of Danish business angels.

Foto: PR / Magcath

About three years ago, Seed Capital invested millions in the small Danish medtech firm MagCath to help the company obtain CE marking of its urinary catheter for women in 2018. Since then, the company has been rather quiet and the CE marking was postponed.

MagCath now hopes to receive the CE marking in the summer or late summer 2020. According to CEO Niels Erikstrup, postponement was a deliberate choice.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Selvtests til skoleelever er på lager – nyt udbud sat i gang

Der ligger antigentests klar på lager fra tidligere indkøb, og de dækker i første omgang behovet for selvtests til skoleelever, som Regeringen og KL forleden besluttede skal supplere de kommunale skolers testindsats. En nyt udbud er netop skudt i gang for at dække efterspørgslen, når lagrene er tømte, oplyser styrelse.

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier